Ocular toxicity and distribution of subconjunctival and intravitreal rapamycin in horses

In vitro photosensitivity of rapamycin (RAPA) and ocular toxicity and distribution of intravitreal and subconjunctival RAPA was evaluated in normal horses. RAPA (2.5 mg, 5 mg, and 10 mg) was placed in 10 mL of PBS and maintained in a water bath at 37 °C, kept in the dark or subjected to room light,...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of veterinary pharmacology and therapeutics 2008-12, Vol.31 (6), p.511-516
Hauptverfasser: DOUGLAS, L.C, YI, N.Y, DAVIS, J.L, SALMON, J.H, GILGER, B.C
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 516
container_issue 6
container_start_page 511
container_title Journal of veterinary pharmacology and therapeutics
container_volume 31
creator DOUGLAS, L.C
YI, N.Y
DAVIS, J.L
SALMON, J.H
GILGER, B.C
description In vitro photosensitivity of rapamycin (RAPA) and ocular toxicity and distribution of intravitreal and subconjunctival RAPA was evaluated in normal horses. RAPA (2.5 mg, 5 mg, and 10 mg) was placed in 10 mL of PBS and maintained in a water bath at 37 °C, kept in the dark or subjected to room light, and sampled for up to 3 months for RAPA levels. Six normal adult horses received either 5 mg (n = 2) or 10 mg (n = 2) of RAPA intravitreally or 10 mg (n = 2) subconjunctivally. Ophthalmic exams and electroretinography (ERG) were performed prior to injection and on days 1, 7, 14, and 21 post-injection. Eyes were enucleated and samples were collected for RAPA concentrations and histopathology. No difference in light vs. dark RAPA concentrations was observed, suggesting a lack of RAPA phototoxicity. No evidence of ocular toxicity was noted on ophthalmic examination or histopathology. RAPA was not detected intraocularly 7 days post-injection in eyes receiving subconjunctival RAPA, but was detected in the vitreous at 21 days post-injection. Drug could be detected in both the aqueous and vitreous humor after intravitreal injection. Further study is needed to determine the efficacy of intravitreal RAPA.
doi_str_mv 10.1111/j.1365-2885.2008.00986.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_745633637</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>745633637</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4606-8bd7d5fe0491d012878d75772582b45b321c99eb610196aba95074c247ab60773</originalsourceid><addsrcrecordid>eNqNkE1v1DAQhi0EokvhL0BunBLGdvwRiQutaEspFAkK3CzbccBLNl7spOz-e5xmVa7MZUbj5x1LD0IFhgrnerWuMOWsJFKyigDICqCRvNo9QKv7h4doBbiGUghJj9CTlNYAQCXGj9ERbvJMBFmh79d26nUsxrDz1o_7Qg9t0fo0Rm-m0YehCF2RJmPDsJ4GO_pb3d8xfhijvvVjdHkR9VZv9tYPeV38DDG59BQ96nSf3LNDP0Y3Z2-_nF6UV9fn707fXJW25sBLaVrRss5B3eAWMJFCtoIJQZgkpmaGEmybxhmOATdcG90wELUltdCGgxD0GL1c7m5j-D25NKqNT9b1vR5cmJISNeOUcjqTciFtDClF16lt9Bsd9wqDmrWqtZrtqdmemrWqO61ql6PPD59MZuPaf8GDxwy8XoA_vnf7_z6sLr9-ykOOl0s8i3e7-7iOvxQXVDD17eO5en_GL0_4xQd1kvkXC9_poPSP6JO6-UwAU8CMQ1NL-hcqSZ6L</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>745633637</pqid></control><display><type>article</type><title>Ocular toxicity and distribution of subconjunctival and intravitreal rapamycin in horses</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>DOUGLAS, L.C ; YI, N.Y ; DAVIS, J.L ; SALMON, J.H ; GILGER, B.C</creator><creatorcontrib>DOUGLAS, L.C ; YI, N.Y ; DAVIS, J.L ; SALMON, J.H ; GILGER, B.C</creatorcontrib><description>In vitro photosensitivity of rapamycin (RAPA) and ocular toxicity and distribution of intravitreal and subconjunctival RAPA was evaluated in normal horses. RAPA (2.5 mg, 5 mg, and 10 mg) was placed in 10 mL of PBS and maintained in a water bath at 37 °C, kept in the dark or subjected to room light, and sampled for up to 3 months for RAPA levels. Six normal adult horses received either 5 mg (n = 2) or 10 mg (n = 2) of RAPA intravitreally or 10 mg (n = 2) subconjunctivally. Ophthalmic exams and electroretinography (ERG) were performed prior to injection and on days 1, 7, 14, and 21 post-injection. Eyes were enucleated and samples were collected for RAPA concentrations and histopathology. No difference in light vs. dark RAPA concentrations was observed, suggesting a lack of RAPA phototoxicity. No evidence of ocular toxicity was noted on ophthalmic examination or histopathology. RAPA was not detected intraocularly 7 days post-injection in eyes receiving subconjunctival RAPA, but was detected in the vitreous at 21 days post-injection. Drug could be detected in both the aqueous and vitreous humor after intravitreal injection. Further study is needed to determine the efficacy of intravitreal RAPA.</description><identifier>ISSN: 0140-7783</identifier><identifier>EISSN: 1365-2885</identifier><identifier>DOI: 10.1111/j.1365-2885.2008.00986.x</identifier><identifier>PMID: 19000272</identifier><language>eng</language><publisher>Oxford, UK: Oxford, UK : Blackwell Publishing Ltd</publisher><subject>Animals ; Anti-Bacterial Agents - adverse effects ; Anti-Bacterial Agents - pharmacokinetics ; Anti-Bacterial Agents - therapeutic use ; antibiotics ; aqueous humor ; chemical concentration ; Chromatography, High Pressure Liquid ; conjunctiva ; Dermatitis, Phototoxic ; dosage ; drug evaluation ; drug injection ; drug toxicity ; electroretinography ; eyes ; histopathology ; Horses ; intravitreal injection ; pharmacokinetics ; photostability ; Sirolimus - adverse effects ; Sirolimus - pharmacokinetics ; Sirolimus - therapeutic use ; subconjunctival injection ; Tissue Distribution ; Uveitis - drug therapy ; Uveitis - veterinary ; vitreous humor</subject><ispartof>Journal of veterinary pharmacology and therapeutics, 2008-12, Vol.31 (6), p.511-516</ispartof><rights>2008 The Authors. Journal compilation © 2008 Blackwell Publishing Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4606-8bd7d5fe0491d012878d75772582b45b321c99eb610196aba95074c247ab60773</citedby><cites>FETCH-LOGICAL-c4606-8bd7d5fe0491d012878d75772582b45b321c99eb610196aba95074c247ab60773</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1365-2885.2008.00986.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1365-2885.2008.00986.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19000272$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>DOUGLAS, L.C</creatorcontrib><creatorcontrib>YI, N.Y</creatorcontrib><creatorcontrib>DAVIS, J.L</creatorcontrib><creatorcontrib>SALMON, J.H</creatorcontrib><creatorcontrib>GILGER, B.C</creatorcontrib><title>Ocular toxicity and distribution of subconjunctival and intravitreal rapamycin in horses</title><title>Journal of veterinary pharmacology and therapeutics</title><addtitle>J Vet Pharmacol Ther</addtitle><description>In vitro photosensitivity of rapamycin (RAPA) and ocular toxicity and distribution of intravitreal and subconjunctival RAPA was evaluated in normal horses. RAPA (2.5 mg, 5 mg, and 10 mg) was placed in 10 mL of PBS and maintained in a water bath at 37 °C, kept in the dark or subjected to room light, and sampled for up to 3 months for RAPA levels. Six normal adult horses received either 5 mg (n = 2) or 10 mg (n = 2) of RAPA intravitreally or 10 mg (n = 2) subconjunctivally. Ophthalmic exams and electroretinography (ERG) were performed prior to injection and on days 1, 7, 14, and 21 post-injection. Eyes were enucleated and samples were collected for RAPA concentrations and histopathology. No difference in light vs. dark RAPA concentrations was observed, suggesting a lack of RAPA phototoxicity. No evidence of ocular toxicity was noted on ophthalmic examination or histopathology. RAPA was not detected intraocularly 7 days post-injection in eyes receiving subconjunctival RAPA, but was detected in the vitreous at 21 days post-injection. Drug could be detected in both the aqueous and vitreous humor after intravitreal injection. Further study is needed to determine the efficacy of intravitreal RAPA.</description><subject>Animals</subject><subject>Anti-Bacterial Agents - adverse effects</subject><subject>Anti-Bacterial Agents - pharmacokinetics</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>antibiotics</subject><subject>aqueous humor</subject><subject>chemical concentration</subject><subject>Chromatography, High Pressure Liquid</subject><subject>conjunctiva</subject><subject>Dermatitis, Phototoxic</subject><subject>dosage</subject><subject>drug evaluation</subject><subject>drug injection</subject><subject>drug toxicity</subject><subject>electroretinography</subject><subject>eyes</subject><subject>histopathology</subject><subject>Horses</subject><subject>intravitreal injection</subject><subject>pharmacokinetics</subject><subject>photostability</subject><subject>Sirolimus - adverse effects</subject><subject>Sirolimus - pharmacokinetics</subject><subject>Sirolimus - therapeutic use</subject><subject>subconjunctival injection</subject><subject>Tissue Distribution</subject><subject>Uveitis - drug therapy</subject><subject>Uveitis - veterinary</subject><subject>vitreous humor</subject><issn>0140-7783</issn><issn>1365-2885</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkE1v1DAQhi0EokvhL0BunBLGdvwRiQutaEspFAkK3CzbccBLNl7spOz-e5xmVa7MZUbj5x1LD0IFhgrnerWuMOWsJFKyigDICqCRvNo9QKv7h4doBbiGUghJj9CTlNYAQCXGj9ERbvJMBFmh79d26nUsxrDz1o_7Qg9t0fo0Rm-m0YehCF2RJmPDsJ4GO_pb3d8xfhijvvVjdHkR9VZv9tYPeV38DDG59BQ96nSf3LNDP0Y3Z2-_nF6UV9fn707fXJW25sBLaVrRss5B3eAWMJFCtoIJQZgkpmaGEmybxhmOATdcG90wELUltdCGgxD0GL1c7m5j-D25NKqNT9b1vR5cmJISNeOUcjqTciFtDClF16lt9Bsd9wqDmrWqtZrtqdmemrWqO61ql6PPD59MZuPaf8GDxwy8XoA_vnf7_z6sLr9-ykOOl0s8i3e7-7iOvxQXVDD17eO5en_GL0_4xQd1kvkXC9_poPSP6JO6-UwAU8CMQ1NL-hcqSZ6L</recordid><startdate>200812</startdate><enddate>200812</enddate><creator>DOUGLAS, L.C</creator><creator>YI, N.Y</creator><creator>DAVIS, J.L</creator><creator>SALMON, J.H</creator><creator>GILGER, B.C</creator><general>Oxford, UK : Blackwell Publishing Ltd</general><general>Blackwell Publishing Ltd</general><scope>FBQ</scope><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U7</scope><scope>C1K</scope></search><sort><creationdate>200812</creationdate><title>Ocular toxicity and distribution of subconjunctival and intravitreal rapamycin in horses</title><author>DOUGLAS, L.C ; YI, N.Y ; DAVIS, J.L ; SALMON, J.H ; GILGER, B.C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4606-8bd7d5fe0491d012878d75772582b45b321c99eb610196aba95074c247ab60773</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Animals</topic><topic>Anti-Bacterial Agents - adverse effects</topic><topic>Anti-Bacterial Agents - pharmacokinetics</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>antibiotics</topic><topic>aqueous humor</topic><topic>chemical concentration</topic><topic>Chromatography, High Pressure Liquid</topic><topic>conjunctiva</topic><topic>Dermatitis, Phototoxic</topic><topic>dosage</topic><topic>drug evaluation</topic><topic>drug injection</topic><topic>drug toxicity</topic><topic>electroretinography</topic><topic>eyes</topic><topic>histopathology</topic><topic>Horses</topic><topic>intravitreal injection</topic><topic>pharmacokinetics</topic><topic>photostability</topic><topic>Sirolimus - adverse effects</topic><topic>Sirolimus - pharmacokinetics</topic><topic>Sirolimus - therapeutic use</topic><topic>subconjunctival injection</topic><topic>Tissue Distribution</topic><topic>Uveitis - drug therapy</topic><topic>Uveitis - veterinary</topic><topic>vitreous humor</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>DOUGLAS, L.C</creatorcontrib><creatorcontrib>YI, N.Y</creatorcontrib><creatorcontrib>DAVIS, J.L</creatorcontrib><creatorcontrib>SALMON, J.H</creatorcontrib><creatorcontrib>GILGER, B.C</creatorcontrib><collection>AGRIS</collection><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>Journal of veterinary pharmacology and therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>DOUGLAS, L.C</au><au>YI, N.Y</au><au>DAVIS, J.L</au><au>SALMON, J.H</au><au>GILGER, B.C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ocular toxicity and distribution of subconjunctival and intravitreal rapamycin in horses</atitle><jtitle>Journal of veterinary pharmacology and therapeutics</jtitle><addtitle>J Vet Pharmacol Ther</addtitle><date>2008-12</date><risdate>2008</risdate><volume>31</volume><issue>6</issue><spage>511</spage><epage>516</epage><pages>511-516</pages><issn>0140-7783</issn><eissn>1365-2885</eissn><abstract>In vitro photosensitivity of rapamycin (RAPA) and ocular toxicity and distribution of intravitreal and subconjunctival RAPA was evaluated in normal horses. RAPA (2.5 mg, 5 mg, and 10 mg) was placed in 10 mL of PBS and maintained in a water bath at 37 °C, kept in the dark or subjected to room light, and sampled for up to 3 months for RAPA levels. Six normal adult horses received either 5 mg (n = 2) or 10 mg (n = 2) of RAPA intravitreally or 10 mg (n = 2) subconjunctivally. Ophthalmic exams and electroretinography (ERG) were performed prior to injection and on days 1, 7, 14, and 21 post-injection. Eyes were enucleated and samples were collected for RAPA concentrations and histopathology. No difference in light vs. dark RAPA concentrations was observed, suggesting a lack of RAPA phototoxicity. No evidence of ocular toxicity was noted on ophthalmic examination or histopathology. RAPA was not detected intraocularly 7 days post-injection in eyes receiving subconjunctival RAPA, but was detected in the vitreous at 21 days post-injection. Drug could be detected in both the aqueous and vitreous humor after intravitreal injection. Further study is needed to determine the efficacy of intravitreal RAPA.</abstract><cop>Oxford, UK</cop><pub>Oxford, UK : Blackwell Publishing Ltd</pub><pmid>19000272</pmid><doi>10.1111/j.1365-2885.2008.00986.x</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0140-7783
ispartof Journal of veterinary pharmacology and therapeutics, 2008-12, Vol.31 (6), p.511-516
issn 0140-7783
1365-2885
language eng
recordid cdi_proquest_miscellaneous_745633637
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Animals
Anti-Bacterial Agents - adverse effects
Anti-Bacterial Agents - pharmacokinetics
Anti-Bacterial Agents - therapeutic use
antibiotics
aqueous humor
chemical concentration
Chromatography, High Pressure Liquid
conjunctiva
Dermatitis, Phototoxic
dosage
drug evaluation
drug injection
drug toxicity
electroretinography
eyes
histopathology
Horses
intravitreal injection
pharmacokinetics
photostability
Sirolimus - adverse effects
Sirolimus - pharmacokinetics
Sirolimus - therapeutic use
subconjunctival injection
Tissue Distribution
Uveitis - drug therapy
Uveitis - veterinary
vitreous humor
title Ocular toxicity and distribution of subconjunctival and intravitreal rapamycin in horses
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T08%3A52%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ocular%20toxicity%20and%20distribution%20of%20subconjunctival%20and%20intravitreal%20rapamycin%20in%20horses&rft.jtitle=Journal%20of%20veterinary%20pharmacology%20and%20therapeutics&rft.au=DOUGLAS,%20L.C&rft.date=2008-12&rft.volume=31&rft.issue=6&rft.spage=511&rft.epage=516&rft.pages=511-516&rft.issn=0140-7783&rft.eissn=1365-2885&rft_id=info:doi/10.1111/j.1365-2885.2008.00986.x&rft_dat=%3Cproquest_cross%3E745633637%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=745633637&rft_id=info:pmid/19000272&rfr_iscdi=true